M EN3 (Eprosartan Mesylate 600 mg)
Pill with imprint M EN3 is White, Capsule-shape and has been identified as Eprosartan Mesylate 600 mg. It is supplied by Matrix Laboratories Limited .
Eprosartan is used in the treatment of high blood pressure and belongs to the drug class angiotensin receptor blockers. There is positive evidence of human fetal risk during pregnancy. Eprosartan 600 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M EN3
Eprosartan Mesylate
- Imprint
- M EN3
- Strength
- 600 mg
- Color
- White
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Angiotensin receptor blockers
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Matrix Laboratories Limited
- National Drug Code (NDC)
- 00378-6629 (Discontinued)
- Inactive Ingredients
-
ammonia,
ferrosoferric oxide,
silicon dioxide,
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
polysorbate 80,
corn starch,
propylene glycol,
shellac,
titanium dioxide
Note: Inactive ingredients may vary.
Related Images for "M EN3"
More about eprosartan
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Drug images
- Drug class: angiotensin receptor blockers
Patient resources
- Other brands
- Teveten
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.